Drug intelligence / Profile preview

polysporin triple therapy

Development stage
Phase 4
Lead developer
Johnson & Johnson
Modality
Drug Delivery Systems, Small Molecules
Administration
Topical
01

Overview

Polysporin Triple Therapy is a topical combination antibiotic ointment containing three active ingredients: polymyxin B sulfate, bacitracin zinc, and gramicidin. It is used to prevent infection and promote healing in minor cuts, scrapes, burns, and certain skin infections. The mechanism of action involves broad-spectrum antibacterial activity: - Bacitracin zinc inhibits bacterial cell wall synthesis by interfering with the regeneration of phospholipid receptors involved in peptidoglycan synthesis. - Polymyxin B sulfate increases the permeability of the bacterial cell membrane by interacting with its phospholipid components. - Gramicidin disrupts bacterial cell membranes by forming channels that allow ions to pass through. This combination provides coverage against a wide range of gram-positive and gram-negative bacteria. It is intended for external use only on minor wounds or skin infections[1][2][4][7].

Brand names
Polysporin Triple Antibiotic OintmentPolysporin Triple AntibioPOLYSPORIN Triple Therapy
Other names
polysporin triple therapypolymyxin B sulfate - bacitracin zinc - gramicidin ointment
02

Targets

LPS (Lipopolysaccharide)C55-PP (Undecaprenyl pyrophosphate)

Beyond the preview

Go deeper on polysporin triple therapy.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on polysporin triple therapy.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call